Lv11
40 积分 2025-03-20 加入
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
3小时前
待确认
Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study
3个月前
已完结
Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data
5个月前
已完结
Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use
5个月前
已完结
Risedronate clinical efficacy and bisphosphonate new effectiveness data from real world clinical practice
8个月前
已完结
Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study
8个月前
已完结
Real world clinical outcomes when discontinuing denosumab or bisphosphonates in patients with surgically managed osteoporotic vertebral compression fractures: a population-based cohort study
8个月前
已完结
Comparative cardiovascular safety of romosozumab versus bisphosphonates in Japanese patients with osteoporosis: a new-user, active comparator design with instrumental variable analyses
8个月前
已完结
Cardiovascular Safety and Fracture Prevention Effectiveness of Denosumab Versus Oral Bisphosphonates in Patients Receiving Dialysis
8个月前
已完结
Osteoarthritis risk associated with romosozumab compared with teriparatide in individuals with osteoporosis: a target trial emulation study
9个月前
已关闭
皖公网安备34019202002308
